Patents
Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
04/2006
04/05/2006CN1756740A Nitrogenous heterocyclic derivative having 2,6-disubstituted styryl
04/05/2006CN1754877A Anthracene derivative and organic electroluminescence device using the derivative
04/05/2006CN1754623A Catalyst and its preparation method and use of the said catalyst in 5h-dibenzanthracene-(b,f)-aza
04/04/2006US7022716 Cyclic amine phenyl beta-3 adrenergic receptor agonists
04/04/2006US7022690 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use
04/04/2006CA2241787C Substituted aza- and diazacycloheptane and cyclooctane compounds and their use
03/2006
03/30/2006US20060069083 Pesticidal dibenzo(hetero)azepine derivatives
03/29/2006EP1638939A2 Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
03/29/2006CN1753892A Tetrahydro-4h-pyrido[1,2-a]pyrimidines and related compounds useful as HIV integrase inhibitors
03/29/2006CN1247545C Method of eliminating miniature amount of impurities in epsilon-caprolactam water solution
03/29/2006CN1247541C Cyclic imines as pesticides
03/28/2006US7019024 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
03/28/2006US7018642 Compounds, compositions, and methods for controlling biofilms
03/23/2006WO2006031550A1 Separation of 6-aminocapronitrile and hexamethylenediamine from a mixture comprising hexamethylenediamine, 6-aminocapronitrle and tetrahydroazepine
03/23/2006US20060063769 Preventives/remedies for urinary disturbance
03/23/2006US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease
03/22/2006EP1637141A1 Stabilized protease composition comprising a serine protease, morpholino derivatives and reversible inhibitors of said serine protease
03/22/2006EP1636196A1 Novel lactams and uses thereof
03/22/2006EP1636191A2 Benzazepine derivatives useful for the treatment of 5ht2c receptor associated diseases
03/22/2006EP1636178A1 Method for making caprolactam
03/22/2006CN1246315C Amino alkoxybenzoyl-benzofuran or benzothiophene derivatives, methods for preparing same and compositions containing same
03/21/2006US7015322 Reacting iminostilbene with an alkali cyanate in an aqueous acetic acid solution
03/21/2006US7015320 Process for the manufacture of optically active 3-substituted lactams by asymmetric hydrogenation of 3-alkylidenelactams
03/21/2006CA2282254C Hydroxyazepanes as inhibitors of glycosidase and hiv protease
03/15/2006EP1633721A1 Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives
03/15/2006EP1633720A1 Benzazepine derivatives useful for the treatment of 5ht2c receptor associated diseases
03/15/2006EP1633719A2 Substituted spirobenzazepines
03/15/2006EP1633706A1 Process for preparing caprolactam by beckmann rearrangement
03/15/2006EP1448566B1 Chemokine receptor antagonists and methods of use thereof
03/15/2006EP1444206B1 Substituted benzo[b]azepin-2-one compounds as analgesics
03/14/2006US7012098 Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers
03/14/2006CA2289987C Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia
03/14/2006CA2239547C Benzazepine derivatives with vasopressin agonistic activity
03/09/2006US20060052588 Novel nitrosation polymer in organic synthesis
03/09/2006US20060052365 Protease inhibitors
03/09/2006CA2577964A1 Ligands for g-protein coupled receptors
03/08/2006EP1632477A1 Benzamide derivative or salt thereof
03/08/2006EP1631560A2 C-fms kinase inhibitors
03/08/2006EP1365761B1 Therapeutic combination of amlodipine and benazepril
03/08/2006EP1335904B1 Production of alkyl 6-aminocaproate
03/08/2006EP1328527B1 Cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including those resistant to usual chemotherapeutic agents and as reversal agents
03/08/2006CN1745076A Malonamide derivatives as gamma-secretase inhibitors
03/08/2006CN1244563C Dibenzo [b,f] azepine intermediates
03/08/2006CN1244561C Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
03/08/2006CN1244545C Production of 6-aminocaproic acid
03/07/2006US7008939 Use of weak opioids and mixed opioid agonists/antagonists for treatment of urinary incontinence
03/07/2006US7008938 Benzene-fused heteroring derivatives and pharmaceutical agents comprising the same as active ingredient
03/02/2006WO2006021213A2 Vasopressin v1a antagonists
03/02/2006US20060046985 Tetrahydro--4h-pyrido[1,2-a}pyrimidines and related compounds useful as hiv integrase inhibitors
03/01/2006EP1628955A1 Continuous process for preparing caprolactam
03/01/2006EP1628949A2 Process and intermediates for preparing benzazepines
03/01/2006CN1741986A Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
03/01/2006CN1243724C Amide derivatives which are useful as cell factor inhibitors
02/2006
02/28/2006US7005436 Heterocyclo inhibitors of potassium channel function
02/23/2006WO2006018260A1 Tetrahydrobenzazepines as antagonists and/or reverse agonists of the histamine h 3 receptor
02/23/2006US20060040919 N-substituted-(dihydroisoquinoline or tetrahydro 2- or 3- benzazepine)-2-carbothioamides; blocking agents; asthma, chronic obstructive pulmonary disease, bronchiectasis, cystic fibrosis, bronchiolitis or bronchopulmonary dysplasia; coadministering with a beta 2-agonist, anticholinergic agent or corticoid
02/23/2006US20060040918 Benzo d!azepine derivatives for the treatment of neurological disorders
02/23/2006CA2577060A1 Substituted benzofused heterocycles
02/22/2006CN1242988C Method for preparing caprolactam
02/21/2006US7001898 Treating conditions involving increased vascular resistance and cardiac insufficiency.
02/16/2006WO2006016152A1 Anti-inflammatory agents
02/16/2006CA2576257A1 Anti-inflammatory agents
02/16/2006CA2575808A1 Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds
02/15/2006EP1008346B1 NF-kB INHIBITORS CONTAINING BENZOQUINONE DERIVATIVES
02/15/2006CN1733708A Anti-hepatitis B virus tertiary amine oxide and preparation method and uses for manufacturing drug
02/15/2006CN1241924C Method for preparing enkephalinase and angiotensin-converting enzyme inhibitor intermediate and its intermediate
02/14/2006US6998398 use in improvement of gastrointestinal blood flow, in treatment of hypertension and in treatment and prophylaxis of cardiac damages induced by adriamycin and comparable anti-cancer drugs
02/14/2006CA2248598C Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
02/14/2006CA2105666C New centrally acting substituted phenylazacycloalkanes
02/09/2006WO2006014703A2 Homopiperdinine derivatives as nk-1 antagonists
02/09/2006WO2006014206A1 Prostaglandin analogs
02/09/2006WO2006014135A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression
02/09/2006CA2576109A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression
02/08/2006EP1059977B1 Recovery of organic solutes from aqueous solutions
02/08/2006CN1240699C Remedies or preventives for diseases in association with chemokines
02/07/2006CA2360308C Glucocorticoid receptor modulators
02/02/2006US20060025587 Process for the preparation of alpha-aminosubstituted carboxylic acid amides
02/02/2006US20060025407 Succinoylaminobenzodiazepines as inhibitors of Abeta protein production
02/02/2006US20060024523 Organic electroluminescence device
02/02/2006DE102004031620A1 4-Trifluormethoxyphenoxybenzol-4`-sulfonsäuren, Verfahren zu ihrer Herstellung und Verwendung in Arzneimitteln 4-Trifluormethoxyphenoxybenzol-4`-sulfonic acids, process for their preparation and use in pharmaceuticals
02/01/2006EP1119563B1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
02/01/2006EP1044586B1 Method for fabricating highly transparent non-metallic cathodes
01/2006
01/31/2006US6992205 Process for the production of sulfonic esters
01/31/2006US6992103 amidation and/or dehalogenation to form substituted [4-carbamoyl-2-hydroxypentyl]-benzamides; potent enzyme inhibitors of Asp2 [B-secretase, BACE1 (b-site Alzheimer's amyloid precursor protein cleaving enzyme) or Memapsin]; Alzheimer's disease
01/31/2006US6992079 Antiproliferative agent
01/31/2006US6992078 Solvent extraction, separation, crystallization
01/31/2006US6992077 Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof
01/31/2006CA2314154C Azepine or larger medium ring derivatives and their use as pharmaceuticals
01/26/2006US20060020041 substituted ethylene diamines such as N-Geranyl-N'-(2-adamanthyl)ethane-1,2-diamine, used for the treatment of leprosy or tuberculosis caused by mycobacterial infections
01/26/2006US20060019943 Homopiperidine derivatives as NK-1 antagonists
01/25/2006EP1619189A1 N-(3-acyl-2-hydroxyalkyl) cycloalkyl amide derivatives
01/25/2006EP1619185A1 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivative or salt thereof
01/25/2006CN1726042A Benzo[d]azepine derivatives for the treatment of neurological disorders
01/24/2006US6989444 Process for producing lactam
01/24/2006US6989402 Thyroid receptor ligands and method II
01/19/2006WO2006005951A1 Method for chiral inversion of (s)-(+)- and (r)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and optically enriched mixtures thereof
01/19/2006WO2006005486A1 Sulfonamide derivatives
01/19/2006WO2004113297A3 Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
01/19/2006US20060014945 Sulfonamides
01/19/2006US20060014792 Heterocyclo inhibitors of potassium channel function
1 ... 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 ... 88